Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy NeuroNEXT and the National Institute of Neurological Disorders and Stroke (NINDS) are undergoing a double-blind, placebo clinical trial looking at the effectiveness of treating peripheral neuropathy with the FDA-approved drug,... read more → June 7, 2018 No Comments Clinical Trials, Research, Research Studies, Uncategorized